EGF样域蛋白7(EGFL7)多克隆抗体
Polyclonal Antibody to EGF Like Domain Protein, Multiple 7 (EGFL7)
ZNEU1; MEGF7; Zneu1; Vascular endothelial statin; EGF Like Domain Containing 7; Epidermal growth factor-like protein 7; Multiple epidermal growth factor-like domains protein 7
- 编号PAL643Mu01
- 物种Mus musculus (Mouse，小鼠) 相同的名称，不同的物种。
- 来源多抗制备
- 宿主兔
- 效价-
- Ig类型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原 RPL643Mu01-EGF样域蛋白7(EGFL7)重组蛋白
- 缓冲液成份0.01M 磷酸盐缓冲液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性状液体
- 浓度500µg/mL
- 且适物种Rattus norvegicus (Rat，大鼠)
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术，请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 713 ¥ 1663 ¥ 2376 ¥ 5940 ¥ 23760
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
DAB staining on IHC-P; Samples: Mouse Kidney Tissue; Primary Ab: 20μg/ml Rabbit Anti-Mouse EGFL7 Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant EGFL7, Mouse.
-
Figure. Western Blot; Sample: Mouse Heart Tissue.
-
通过ISO 9001、ISO 13485质量体系认证
特异性
该抗体是针对EGFL7的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别EGFL7。
用法
Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
赠品
增值服务
相关产品
| 编号 | 适用物种：Mus musculus (Mouse，小鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPL643Mu01 | EGF样域蛋白7(EGFL7)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPL643Mu02 | EGF样域蛋白7(EGFL7)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAL643Mu02 | EGF样域蛋白7(EGFL7)多克隆抗体 | WB; IHC; ICC; IP. |
| PAL643Mu01 | EGF样域蛋白7(EGFL7)多克隆抗体 | WB; IHC; ICC; IP. |
| SEL643Mu | EGF样域蛋白7(EGFL7)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LML643Mu | EGF样域蛋白7(EGFL7)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| Scientific Reports | Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab [PMC5443778] |
| Scientific Reports | Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab. [pubmed:28539619] |
| International Journal of Clinical and Experimental Pathology | EGF like domain multiple 7 regulates the migration and invasion of prostate cancer cells [ISSN:1936-2625] |
| Cancer Drug Resist | MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy [] |
留言咨询